These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 5476608)

  • 41. Description and classification of depressive disorders. Contributions for the definition of the therapy-resistance and of therapy resistant depressions.
    Sartorius N
    Pharmakopsychiatr Neuropsychopharmakol; 1974 Mar; 7(2):76-9. PubMed ID: 4438426
    [No Abstract]   [Full Text] [Related]  

  • 42. A controlled study of desipramine in the treatment of hospitalized depressive disorders.
    Vestre ND; Janecek J; Zimmermann R
    Int J Neuropsychiatry; 1967 Aug; 3(4):354-9. PubMed ID: 4863508
    [No Abstract]   [Full Text] [Related]  

  • 43. [1st results with a new antidepressive drug FI6654].
    Lo Grasso G; Losavio T; Matteucci A
    Acta Neurol (Napoli); 1972; 27(4):403-22. PubMed ID: 5085164
    [No Abstract]   [Full Text] [Related]  

  • 44. [Clinical cooperative testing of the antidepressive agent noxiptilin in the University Neuroclinics of Kiel, Mainz and Marburg].
    Boeters U; Grahmann H; Petrilowitsch N; Reckel K; Spiegelberg U
    Arzneimittelforschung; 1969 Jun; 19():Suppl 5a:895+. PubMed ID: 4895494
    [No Abstract]   [Full Text] [Related]  

  • 45. [Effect of neuroleptics on depressive symptoms].
    Tabeze JP
    Encephale; 1998 Jul; 24 Spec No 1():38-41. PubMed ID: 9809254
    [No Abstract]   [Full Text] [Related]  

  • 46. Note on the treatment of depression.
    Denber HC
    Can Psychiatr Assoc J; 1966; 11 Suppl():Suppl:141-5. PubMed ID: 5328013
    [No Abstract]   [Full Text] [Related]  

  • 47. [Clinical experimentation with desipramine with statistical control].
    Kammerer M; Wartel R; Gurfein L; Weil J; Wysoki V; Gelb F
    Ann Med Psychol (Paris); 1968 Jan; 1(1):109-13. PubMed ID: 4870813
    [No Abstract]   [Full Text] [Related]  

  • 48. [Current treatment of depression].
    Kielholz P
    Ther Umsch; 1983 Sep; 40(9):788-96. PubMed ID: 6138874
    [No Abstract]   [Full Text] [Related]  

  • 49. [Effect of luteoliberin].
    Soulairac A; Lambinet H; Neuman JC; Schally AV
    Ann Med Psychol (Paris); 1983; 141(8):876-82. PubMed ID: 6364918
    [No Abstract]   [Full Text] [Related]  

  • 50. [Clinical experience with desipramine in endogenous and involutional depressions].
    Rodová A; Svestka J; Náhunek K
    Act Nerv Super (Praha); 1970 Jan; 12(1):65-6. PubMed ID: 4907396
    [No Abstract]   [Full Text] [Related]  

  • 51. Antidepressive treatment and mood swing patterns in endogenous depression.
    Strian F; Albert W; Klicpera C
    Pharmakopsychiatr Neuropsychopharmakol; 1979 Nov; 12(6):432-7. PubMed ID: 538088
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Geriatric experiences with Aolep].
    Jansen W
    Munch Med Wochenschr; 1966 Sep; 108(39):1926-8. PubMed ID: 6014871
    [No Abstract]   [Full Text] [Related]  

  • 53. Drugs for depression and bipolar disorder.
    Treat Guidel Med Lett; 2010 May; 8(93):35-42. PubMed ID: 20414177
    [No Abstract]   [Full Text] [Related]  

  • 54. [Lithium and depressive states].
    Chazot G; Devic M
    Psychopharmacologie; 1973; 0(0):43-8. PubMed ID: 4599705
    [No Abstract]   [Full Text] [Related]  

  • 55. The effects of antidepressant therapy. A follow-up study.
    Vinarová E; Vinar O
    Act Nerv Super (Praha); 1971; 13(3):162-3. PubMed ID: 5113821
    [No Abstract]   [Full Text] [Related]  

  • 56. [Psychopharmacology and psychiatric nosography].
    Borgna E
    Riv Sper Freniatr Med Leg Alien Ment; 1968 Aug; 92(4):1026-67. PubMed ID: 5738058
    [No Abstract]   [Full Text] [Related]  

  • 57. [Experience with Luvatren in ambulatory psychiatric patients].
    Reiter PJ
    Schweiz Arch Neurol Neurochir Psychiatr; 1969; 104(1):169-78. PubMed ID: 5801171
    [No Abstract]   [Full Text] [Related]  

  • 58. Experimental therapy of mental diseases with Edan, with special reference to rheumatic background.
    Cwynar S; Frydrychiewicz T; Napieralska M; Posel Z; Siuchnińska H; Wojdyslawska-Wald I; Zimny S
    Mater Med Pol; 1972; 4(4):213-7. PubMed ID: 4544542
    [No Abstract]   [Full Text] [Related]  

  • 59. Is unrecognized bipolar disorder a frequent contributor to apparent treatment resistant depression?
    Correa R; Akiskal H; Gilmer W; Nierenberg AA; Trivedi M; Zisook S
    J Affect Disord; 2010 Dec; 127(1-3):10-8. PubMed ID: 20655113
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ketamine as an alternative treatment for treatment-resistant depression.
    Dowben JS; Grant JS; Keltner NL
    Perspect Psychiatr Care; 2013 Jan; 49(1):2-4. PubMed ID: 23293991
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.